Your browser doesn't support javascript.
loading
Combination therapy with remdesivir and immunomodulators improves respiratory status in COVID-19: A retrospective study.
Kojima, Yuichi; Nakakubo, Sho; Kamada, Keisuke; Yamashita, Yu; Takei, Nozomu; Nakamura, Junichi; Matsumoto, Munehiro; Horii, Hiroshi; Sato, Kazuki; Shima, Hideki; Suzuki, Masaru; Konno, Satoshi.
Afiliación
  • Kojima Y; Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Nakakubo S; Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Kamada K; Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Yamashita Y; Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan.
  • Takei N; Department of Epidemiology and Clinical Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan.
  • Nakamura J; Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Matsumoto M; Department of Respiratory Medicine 1, Obihiro Kosei General Hospital, Obihiro, Japan.
  • Horii H; Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Sato K; Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Shima H; Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Suzuki M; Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Konno S; Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
J Med Virol ; 94(12): 5702-5712, 2022 12.
Article en En | MEDLINE | ID: mdl-35916111

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Med Virol Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Med Virol Año: 2022 Tipo del documento: Article País de afiliación: Japón